These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

644 related items for PubMed ID: 26269025

  • 1. Increased Serum IgA in Children with IgA Nephropathy, Severity of Kidney Biopsy Findings and Long-Term Outcomes.
    Mizerska-Wasiak M, Małdyk J, Pańczyk-Tomaszewska M, Turczyn A, Cichoń-Kawa K, Rybi-Szumińska A, Wasilewska A, Firszt-Adamczyk A, Stankiewicz R, Bieniaś B, Zajączkowska M, Gadomska-Prokop K, Grenda R, Miklaszewska M, Pietrzyk J, Pukajło-Marczyk, Zwolińska D, Szczepańska M, Demkow U, Roszkowska-Blaim M.
    Adv Exp Med Biol; 2015; 873():79-86. PubMed ID: 26269025
    [Abstract] [Full Text] [Related]

  • 2. Predictors of Progression in IgA Nephropathy in Childhood.
    Mizerska-Wasiak M, Małdyk J, Turczyn A, Cichoń-Kawa K, Rybi-Szumińska A, Wasilewska A, Bieniaś B, Zajączkowska M, Miklaszewska M, Pietrzyk J, Demkow U, Roszkowska-Blaim M, Pańczyk-Tomaszewska M.
    Adv Exp Med Biol; 2017; 955():65-73. PubMed ID: 27718216
    [Abstract] [Full Text] [Related]

  • 3. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
    Soleymanian T, Najafi I, Salimi BH, Broomand B.
    Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
    [Abstract] [Full Text] [Related]

  • 4. Valsartan combined with clopidogrel and/or leflunomide for the treatment of progressive immunoglobulin A nephropathy.
    Cheng G, Liu D, Margetts P, Liu L, Zhao Z, Liu Z, Tang L, Fang Y, Li H, Guo Y, Chen F, Liu F.
    Nephrology (Carlton); 2015 Feb; 20(2):77-84. PubMed ID: 25358874
    [Abstract] [Full Text] [Related]

  • 5. Treatment of severe Henoch-Schönlein and immunoglobulin A nephritis. A single center experience.
    Edström Halling S, Söderberg MP, Berg UB.
    Pediatr Nephrol; 2009 Jan; 24(1):91-7. PubMed ID: 18931859
    [Abstract] [Full Text] [Related]

  • 6. The effects of cytotoxic therapy in progressive IgA nephropathy.
    Shin JH, Lee JE, Park JH, Lim S, Jang HR, Kwon GY, Huh W, Jung SH, Kim YG, Oh HY, Kim DJ.
    Ann Med; 2016 Jan; 48(3):171-81. PubMed ID: 27031662
    [Abstract] [Full Text] [Related]

  • 7. [Multicenter investigation of therapeutic status of children with IgA nephropathy in China].
    Working Group for National Survey on Status of Diagnosis and Treatment of Childhood Renal Diseases.
    Zhonghua Er Ke Za Zhi; 2013 Jul; 51(7):486-90. PubMed ID: 24267127
    [Abstract] [Full Text] [Related]

  • 8. Treatment and outcome of IgA nephropathy in children from one single center experience.
    Mao Y, Zhou W, Zhou Z, Zhang C, Shen J, Yin L.
    BMC Pediatr; 2023 Jul 26; 23(1):377. PubMed ID: 37495962
    [Abstract] [Full Text] [Related]

  • 9. Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification).
    Edström Halling S, Söderberg MP, Berg UB.
    Nephrol Dial Transplant; 2012 Feb 26; 27(2):715-22. PubMed ID: 21750154
    [Abstract] [Full Text] [Related]

  • 10. [Influence of intensity, localization and type of deposits in renal biopsy for disease symptoms and follow up in children with IgA nephropathy].
    Cichoń-Kawa K, Mizerska-Wasiak M, Małdyk J, Turczyn A, Rybi-Szumińska A, Wasilewska A, Firszt-Adamczyk A, Stankiewicz R, Bieniaś B, Sikora P, Gadomska-Prokop K, Grenda R, Pańczyk-Tomaszewska M.
    Pol Merkur Lekarski; 2018 Apr 23; 44(262):177-182. PubMed ID: 29775444
    [Abstract] [Full Text] [Related]

  • 11. Relationship between serum IgA/C3 ratio and severity of histological lesions using the Oxford classification in children with IgA nephropathy.
    Mizerska-Wasiak M, Małdyk J, Rybi-Szumińska A, Wasilewska A, Miklaszewska M, Pietrzyk J, Firszt-Adamczyk A, Stankiewicz R, Bieniaś B, Zajączkowska M, Gadomska-Prokop K, Grenda R, Pukajło-Marczyk A, Zwolińska D, Szczepańska M, Turczyn A, Roszkowska-Blaim M.
    Pediatr Nephrol; 2015 Jul 23; 30(7):1113-20. PubMed ID: 25549975
    [Abstract] [Full Text] [Related]

  • 12. Membranous nephropathy with crescents: a series of 19 cases.
    Rodriguez EF, Nasr SH, Larsen CP, Sethi S, Fidler ME, Cornell LD.
    Am J Kidney Dis; 2014 Jul 23; 64(1):66-73. PubMed ID: 24709471
    [Abstract] [Full Text] [Related]

  • 13. Effect of hematuria on the outcome of IgA nephropathy with mild proteinuria.
    Tanaka K, Moriyama T, Iwasaki C, Takei T, Nitta K.
    Clin Exp Nephrol; 2015 Oct 23; 19(5):815-21. PubMed ID: 25475403
    [Abstract] [Full Text] [Related]

  • 14. Significance of clinical and morphological prognostic risk factors in IgA nephropathy: follow-up study of comparison patient groups with and without renoprotection.
    Riispere Ž, Kuudeberg A, Seppet E, Sepp K, Ilmoja M, Luman M, Kõlvald K, Auerbach A, Ots-Rosenberg M.
    BMC Nephrol; 2017 Mar 14; 18(1):89. PubMed ID: 28292274
    [Abstract] [Full Text] [Related]

  • 15. [The effects of angiotensin-converting enzyme inhibitor on IgA nephropathy and the influencing factors].
    Shi X, Chen X, Liu S, Zhuang Y, Zhang Y.
    Zhonghua Nei Ke Za Zhi; 2002 Jun 14; 41(6):399-403. PubMed ID: 12137603
    [Abstract] [Full Text] [Related]

  • 16. [Risk factors affecting the long-term outcome of IgA nephropathy].
    Yang NS, Wu QQ, Du Y, Zhang R, Li YJ, Ye RG, Yu XQ.
    Zhonghua Nei Ke Za Zhi; 2005 Aug 14; 44(8):597-600. PubMed ID: 16194415
    [Abstract] [Full Text] [Related]

  • 17. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy.
    Bazzi C, Rizza V, Paparella M, Casellato D, Napodano P, Olivieri G, D'Amico G.
    J Nephrol; 2009 Aug 14; 22(3):387-96. PubMed ID: 19557716
    [Abstract] [Full Text] [Related]

  • 18. IgA Nephropathy in Children: A Multicenter Study in Poland.
    Mizerska-Wasiak M, Turczyn A, Such A, Cichoń-Kawa K, Małdyk J, Miklaszewska M, Pietrzyk J, Rybi-Szumińska A, Wasilewska A, Firszt-Adamczyk A, Stankiewicz R, Szczepańska M, Bieniaś B, Zajączkowska M, Pukajło-Marczyk A, Zwolińska D, Siniewicz-Luzeńczyk K, Tkaczyk M, Gadomska-Prokop K, Grenda R, Demkow U, Pańczyk-Tomaszewska M.
    Adv Exp Med Biol; 2016 Aug 14; 952():75-84. PubMed ID: 27573641
    [Abstract] [Full Text] [Related]

  • 19. Serum IgA/C3 and glomerular C3 staining predict severity of IgA nephropathy.
    Kawasaki Y, Maeda R, Ohara S, Suyama K, Hosoya M.
    Pediatr Int; 2018 Feb 14; 60(2):162-167. PubMed ID: 29178575
    [Abstract] [Full Text] [Related]

  • 20. Association of angiotensin-converting enzyme gene polymorphism and renal pathology in Japanese children with IgA nephropathy.
    Asano T, Tatsuma N, Yoshida J, Ohashi R, Ambo K, Tsuchiya M, Murakami M, Yamanaka N, Honda M, Yamamoto M.
    Clin Nephrol; 1999 Jun 14; 51(6):335-40. PubMed ID: 10404693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.